Treatment of acute coronary syndrome: Part 2: ST-segment elevation myocardial infarction

Jeffrey C. Trost; Richard A. Lange

doi:10.1097/CCM.0b013e31824e18c2

Treatment of acute coronary syndrome: Part 2: ST-segment elevation myocardial infarction

Jeffrey C. Trost, Richard A. Lange

School of Medicine

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

Objective: Familiarize clinicians with recent information regarding the diagnosis and treatment of ST-segment elevation myocardial infarction. Data Sources: PubMed search and review of relevant medical literature. Summary: Definition, pathophysiology, clinical presentation, diagnosis, and treatment of ST-segment elevation myocardial infarction are reviewed. Conclusions: Patients with ST-segment elevation myocardial infarction benefit from prompt reperfusion therapy. Adjunctive antianginal, antiplatelet, antithrombotic, beta blocker, angiotensin-converting enzyme inhibitor, and statin agents minimize ongoing cardiac ischemia, prevent thrombus propagation, and reduce the risk of recurrent cardiovascular events.

Original language	English (US)
Pages (from-to)	1939-1945
Number of pages	7
Journal	Critical care medicine
Volume	40
Issue number	6
DOIs	https://doi.org/10.1097/CCM.0b013e31824e18c2
State	Published - Jun 1 2012

Keywords

acute coronary syndrome
acute myocardial infarction
coronary artery disease

ASJC Scopus subject areas

Critical Care and Intensive Care Medicine

Access to Document

10.1097/CCM.0b013e31824e18c2

Cite this

@article{ebb89d87d403456b85fc960882f4b897,

title = "Treatment of acute coronary syndrome: Part 2: ST-segment elevation myocardial infarction",

abstract = "Objective: Familiarize clinicians with recent information regarding the diagnosis and treatment of ST-segment elevation myocardial infarction. Data Sources: PubMed search and review of relevant medical literature. Summary: Definition, pathophysiology, clinical presentation, diagnosis, and treatment of ST-segment elevation myocardial infarction are reviewed. Conclusions: Patients with ST-segment elevation myocardial infarction benefit from prompt reperfusion therapy. Adjunctive antianginal, antiplatelet, antithrombotic, beta blocker, angiotensin-converting enzyme inhibitor, and statin agents minimize ongoing cardiac ischemia, prevent thrombus propagation, and reduce the risk of recurrent cardiovascular events.",

keywords = "acute coronary syndrome, acute myocardial infarction, coronary artery disease",

author = "Trost, {Jeffrey C.} and Lange, {Richard A.}",

year = "2012",

month = jun,

day = "1",

doi = "10.1097/CCM.0b013e31824e18c2",

language = "English (US)",

volume = "40",

pages = "1939--1945",

journal = "Critical care medicine",

issn = "0090-3493",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Treatment of acute coronary syndrome

T2 - Part 2: ST-segment elevation myocardial infarction

AU - Trost, Jeffrey C.

AU - Lange, Richard A.

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Objective: Familiarize clinicians with recent information regarding the diagnosis and treatment of ST-segment elevation myocardial infarction. Data Sources: PubMed search and review of relevant medical literature. Summary: Definition, pathophysiology, clinical presentation, diagnosis, and treatment of ST-segment elevation myocardial infarction are reviewed. Conclusions: Patients with ST-segment elevation myocardial infarction benefit from prompt reperfusion therapy. Adjunctive antianginal, antiplatelet, antithrombotic, beta blocker, angiotensin-converting enzyme inhibitor, and statin agents minimize ongoing cardiac ischemia, prevent thrombus propagation, and reduce the risk of recurrent cardiovascular events.

AB - Objective: Familiarize clinicians with recent information regarding the diagnosis and treatment of ST-segment elevation myocardial infarction. Data Sources: PubMed search and review of relevant medical literature. Summary: Definition, pathophysiology, clinical presentation, diagnosis, and treatment of ST-segment elevation myocardial infarction are reviewed. Conclusions: Patients with ST-segment elevation myocardial infarction benefit from prompt reperfusion therapy. Adjunctive antianginal, antiplatelet, antithrombotic, beta blocker, angiotensin-converting enzyme inhibitor, and statin agents minimize ongoing cardiac ischemia, prevent thrombus propagation, and reduce the risk of recurrent cardiovascular events.

KW - acute coronary syndrome

KW - acute myocardial infarction

KW - coronary artery disease

UR - http://www.scopus.com/inward/record.url?scp=84861494102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861494102&partnerID=8YFLogxK

U2 - 10.1097/CCM.0b013e31824e18c2

DO - 10.1097/CCM.0b013e31824e18c2

M3 - Review article

C2 - 22610195

AN - SCOPUS:84861494102

SN - 0090-3493

VL - 40

SP - 1939

EP - 1945

JO - Critical care medicine

JF - Critical care medicine

IS - 6

ER -

Treatment of acute coronary syndrome: Part 2: ST-segment elevation myocardial infarction

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this